Quarterly report pursuant to Section 13 or 15(d)


Cover - shares
9 Months Ended
Sep. 30, 2022
Nov. 10, 2022
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2022  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41463  
Entity Registrant Name bioAffinity Technologies, Inc.  
Entity Central Index Key 0001712762  
Entity Tax Identification Number 46-5211056  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 22211 W. Interstate 10  
Entity Address, Address Line Two Suite 1206  
Entity Address, City or Town San Antonio  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78257  
City Area Code (210)  
Local Phone Number 698-5334  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   8,369,750
Common Stock, Par Value $.007 per share [Member]    
Title of 12(b) Security Common Stock, par value $.007 per share  
Trading Symbol BIAF  
Security Exchange Name NASDAQ  
Tradeable Warrants to Purchase Common Stock [Member]    
Title of 12(b) Security Tradeable Warrants to purchase Common Stock  
Trading Symbol BIAFW  
Security Exchange Name NASDAQ